Regenerative Medical Technology (RMTG) EPS (Basic) (QoQ) (2018 - 2026)
Powered by 
Analysis
Regenerative Medical Technology (RMTG) EPS (Basic) (QoQ) (2018 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Krystal Biotech | 10.22 Bn | 9.38 Bn | 112.79 Mn |
| 2 | CRISPR Therapeutics AG | 5.03 Bn | 5.03 Bn | - |
| 3 | Iovance Biotherapeutics | 3.65 Bn | 3.35 Bn | 55.72 Mn |
| 4 | Legend Biotech | 3.54 Bn | 2.57 Bn | 251.50 Mn |
| 5 | uniQure | 2.99 Bn | 2.99 Bn | 5.49 Mn |
| 6 | Beam Therapeutics | 2.52 Bn | 2.52 Bn | - |
| 7 | Precigen | 2.39 Bn | 2.39 Bn | 52.17 Mn |
| 8 | Sarepta Therapeutics | 2.14 Bn | 1.35 Bn | 251.87 Mn |
| 9 | Vericel | 1.93 Bn | 1.77 Bn | 56.40 Mn |
| 10 | Regenerative Medical Technology | 1.12 Mn | -199,206.02 | 2.58 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 15.49% |
| Mar 31, 2026 | 18.52% |
| Dec 31, 2025 | 41.67% |
| Sep 30, 2025 | -201.56% |
| Jun 30, 2025 | -71.57% |
| Mar 31, 2025 | -18.99% |
| Dec 31, 2024 | 27.82% |
| Sep 30, 2024 | 57.48% |
| Jun 30, 2024 | -5.94% |
| Mar 31, 2024 | -10.40% |
| Dec 31, 2023 | -2.03% |
| Sep 30, 2023 | -302.16% |
| Jun 30, 2023 | -480.56% |
| Mar 31, 2023 | 96.95% |
| Dec 31, 2022 | -78.00% |
| Sep 30, 2022 | 10.36% |
| Jun 30, 2022 | 11.98% |
| Mar 31, 2022 | -2.37% |
| Dec 31, 2021 | 83.50% |
| Sep 30, 2021 | -1,196.25% |